Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

Table 2 Meta-analyses of mortality, new AMI, TVR, heart Failure, arrhythmia

Clinical outcomes	Studies included	Effect sizes			Heterogeneity
Clinical outcomes	Studies included	OR	95% CI	P value	Tau²	I² (%)	P value
Mortality	13	0.68	0.41–1.11	0.12	0.00	0	0.83
New AMI	5	0.56	0.19–1.67	0.30	0.00	0	0.90
TVR	8	1.01	0.64–1.59	0.95	0.00	0	0.77
Heart failure	10	0.36	0.23–0.57	0.00	0.00	0	0.55
Arrhythmia	10	0.43	0.31–0.60	0.00	0.00	0	0.91

Arrhythmia refers to ventricular tachycardia and ventricular fibrillation
AMI, acute myocardial infarction; CI, confidence interval; OR, odds ratio; TVR, target vessel revascularization

ISSN: 1471-2261